Janux’s pipeline expansion into autoimmune disease, new immune-oncology product candidates, and over 6-year cash runway ...

Immunologists from UNIGE have discovered the previously unsuspected anti-tumor potential of CD4 T lymphocytes. An important ...

The THR‑β agonist market is witnessing rapid growth, fueled by the increasing global prevalence of metabolic disorders such as MASH and rare genetic ...

Recent advances in computational protein design have depended mainly on neural networks and machine learning to generate ...

A group of Australian scientists has uncovered a new way to fight some of the toughest cancers by targeting an overlooked ...

Insulin resistance is a hallmark of multiple metabolic disorders, including type 2 diabetes, obesity, metabolic syndrome, and polycystic ovary syndrome. It ...

Excessive levels of GABA released by astrocytes impair the brain's ability to extinguish fear responses in PTSD, but a newly ...

Bentham Science presents Promising Cancer Therapeutic Drug Targets: Recent Advancements, a timely and in-depth resource on the latest strategies in cancer treatment. This comprehensive volume presents ...

Non-small cell lung cancer (NSCLC) accounts for over 80% of lung cancer cases and is often diagnosed at advanced stages, ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

The development of drug delivery platforms that offer sustained release of therapeutic agents in the retina represents a ...

A Northeastern University researcher has identified a way to target two of the deadliest cancer types, melanoma and triple ...